Monte Rosa Therapeutics Inc (GLUE) — Cash Flow Quality Index

Latest as of March 2025: -0.97x

Monte Rosa Therapeutics Inc (GLUE) has a Cash Flow Quality Index of -0.97x as of March 2025. Operating cash flow of $-45.49 Million is below net income of $46.88 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Monte Rosa Therapeutics Inc cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.97x

Operating CF / Net Income

Operating Cash Flow

$-45.49 Million

USD

Net Income

$46.88 Million

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Monte Rosa Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Monte Rosa Therapeutics Inc. For live market cap and the full company financial profile, see Monte Rosa Therapeutics Inc (GLUE) total market value.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.